Today, we’re going to piggyback off something our friends at RedState touched upon concerning Moderna not being forthcoming about some data about the vaccine.
Information about the reinfection rate was buried, and an FDA panel member is not too pleased about that development.
...The data that was not presented to the experts looked at actual infections: who caught Covid-19 and who did not.
There are a few observations that can be made here.
...The data that was not presented to the experts looked at actual infections: who caught Covid-19 and who did not.
There are a few observations that can be made here.
- First, omitting critical data to the FDA advisory committee isn’t an oversight.
- The reason they did it is pretty simple. Money.
- And let’s not forget that these pharmaceutical companies have full immunity from legal action...
No comments:
Post a Comment